Annual total expenses:
$211.52M+$45.70M(+27.56%)Summary
- As of today (September 17, 2025), AVDL annual total expenses is $211.52 million, with the most recent change of +$45.70 million (+27.56%) on December 31, 2024.
- During the last 3 years, AVDL annual total expenses has risen by +$125.92 million (+147.10%).
- AVDL annual total expenses is now at all-time high.
Performance
AVDL Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$58.46M+$1.03M(+1.80%)Summary
- As of today (September 17, 2025), AVDL quarterly total expenses is $58.46 million, with the most recent change of +$1.03 million (+1.80%) on June 1, 2025.
- Over the past year, AVDL quarterly total expenses has increased by +$3.14 million (+5.67%).
- AVDL quarterly total expenses is now -31.04% below its all-time high of $84.78 million, reached on December 31, 2018.
Performance
AVDL Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AVDL Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.6% | +5.7% |
| 3 y3 years | +147.1% | -7.8% |
| 5 y5 years | +178.2% | +381.3% |
AVDL Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.1% | -11.3% | +190.2% |
| 5 y | 5-year | at high | +258.5% | -11.3% | +381.3% |
| alltime | all time | at high | +1421.7% | -31.0% | +278.6% |
AVDL Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $58.46M(+1.8%) |
| Mar 2025 | - | $57.43M(+3.6%) |
| Dec 2024 | $211.52M(+27.6%) | $55.45M(+5.3%) |
| Sep 2024 | - | $52.65M(-4.8%) |
| Jun 2024 | - | $55.33M(+1.5%) |
| Mar 2024 | - | $54.52M(+13.0%) |
| Dec 2023 | $165.81M(+74.1%) | $48.24M(+11.4%) |
| Sep 2023 | - | $43.29M(-34.3%) |
| Jun 2023 | - | $65.93M(+114.2%) |
| Mar 2023 | - | $30.78M(+12.1%) |
| Dec 2022 | $95.22M(+11.2%) | $27.45M(+36.3%) |
| Sep 2022 | - | $20.15M(-68.2%) |
| Jun 2022 | - | $63.44M(+140.1%) |
| Mar 2022 | - | $26.42M(+18.5%) |
| Dec 2021 | $85.60M(+45.1%) | $22.30M(+1.4%) |
| Sep 2021 | - | $22.00M(+12.4%) |
| Jun 2021 | - | $19.58M(+45.6%) |
| Mar 2021 | - | $13.45M(+19.2%) |
| Dec 2020 | $58.99M(-22.4%) | $11.28M(-3.6%) |
| Sep 2020 | - | $11.70M(-156.3%) |
| Jun 2020 | - | -$20.78M(-258.6%) |
| Mar 2020 | - | $13.11M(-4.6%) |
| Dec 2019 | $76.04M(-53.6%) | $13.73M(-40.5%) |
| Sep 2019 | - | $23.09M(-11.7%) |
| Jun 2019 | - | $26.16M(-11.2%) |
| Mar 2019 | - | $29.45M(-65.3%) |
| Dec 2018 | $163.82M(+46.0%) | $84.78M(+138.2%) |
| Sep 2018 | - | $35.60M(+9.0%) |
| Jun 2018 | - | $32.67M(-28.2%) |
| Mar 2018 | - | $45.53M(+4.6%) |
| Dec 2017 | $112.24M(+6.0%) | $43.51M(+141.8%) |
| Sep 2017 | - | $18.00M(+3.5%) |
| Jun 2017 | - | $17.38M(-34.6%) |
| Mar 2017 | - | $26.60M(-30.6%) |
| Dec 2016 | $105.93M(+48.6%) | $38.35M(-26.4%) |
| Sep 2016 | - | $52.08M(-11.5%) |
| Jun 2016 | - | $58.82M(+39.1%) |
| Mar 2016 | - | $42.27M(-229.2%) |
| Dec 2015 | $71.29M(+48.1%) | -$32.73M(-142.5%) |
| Sep 2015 | - | $77.00M(+14.6%) |
| Jun 2015 | - | $67.19M(+218.8%) |
| Mar 2015 | - | $21.08M(-39.5%) |
| Dec 2014 | $48.13M(+61.8%) | $34.85M(+104.1%) |
| Sep 2014 | - | $17.07M(-41.4%) |
| Jun 2014 | - | $29.16M(-7.3%) |
| Mar 2014 | - | $31.44M(-2190.4%) |
| Dec 2013 | $29.74M | -$1.50M(-112.6%) |
| Sep 2013 | - | $11.95M(-68.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $38.40M(+174.9%) |
| Mar 2013 | - | $13.97M(-879.5%) |
| Dec 2012 | $29.11M(-31.0%) | -$1.79M(-115.2%) |
| Sep 2012 | - | $11.82M(-1.1%) |
| Jun 2012 | - | $11.95M(+62.6%) |
| Mar 2012 | - | $7.35M(-31.6%) |
| Dec 2011 | $42.18M(-10.1%) | $10.74M(+23.0%) |
| Sep 2011 | - | $8.73M(-14.5%) |
| Jun 2011 | - | $10.21M(-44.6%) |
| Mar 2011 | - | $18.44M(+71.2%) |
| Dec 2010 | $46.93M(-12.9%) | $10.77M(-5.3%) |
| Sep 2010 | - | $11.38M(-3.6%) |
| Jun 2010 | - | $11.80M(-2.5%) |
| Mar 2010 | - | $12.11M(-25.6%) |
| Dec 2009 | $53.87M(+4.0%) | $16.29M(-47.3%) |
| Dec 2008 | $51.80M(-33.2%) | $30.91M(+170.2%) |
| Sep 2008 | - | $11.44M(-8.6%) |
| Jun 2008 | - | $12.51M(-14.1%) |
| Mar 2008 | - | $14.56M(-9.0%) |
| Dec 2007 | $77.50M(+25.3%) | $16.01M(-11.7%) |
| Sep 2007 | - | $18.13M(-14.0%) |
| Jun 2007 | - | $21.08M(+12.8%) |
| Mar 2007 | - | $18.69M(+37.0%) |
| Dec 2006 | $61.86M(-3.9%) | $13.64M(-12.7%) |
| Sep 2006 | - | $15.62M(+10.0%) |
| Jun 2006 | - | $14.20M(-3.8%) |
| Mar 2006 | - | $14.76M(+16.1%) |
| Dec 2005 | $64.37M(+38.2%) | $12.71M(-15.1%) |
| Sep 2005 | - | $14.97M(-2.6%) |
| Jun 2005 | - | $15.37M(+94.1%) |
| Mar 2005 | - | $7.92M(-35.3%) |
| Dec 2004 | $46.58M(+55.9%) | $12.23M(+16.0%) |
| Sep 2004 | - | $10.55M(+0.0%) |
| Jun 2004 | - | $10.55M(+4.9%) |
| Mar 2004 | - | $10.06M(-41.4%) |
| Dec 2003 | $29.87M(+60.3%) | $17.18M(+154.8%) |
| Sep 2003 | - | $6.74M(0.0%) |
| Jun 2003 | - | $6.74M(+13.3%) |
| Mar 2003 | - | $5.95M(+0.5%) |
| Dec 2002 | $18.63M(+14.7%) | $5.92M(+43.2%) |
| Sep 2002 | - | $4.13M(-17.3%) |
| Dec 2001 | $16.24M(-39.9%) | - |
| Dec 2000 | $27.01M(+49.7%) | - |
| Dec 1999 | $18.04M(-4.1%) | - |
| Dec 1998 | $18.81M(+10.0%) | - |
| Mar 1998 | - | $5.00M(+56.3%) |
| Dec 1997 | $17.10M(+23.0%) | - |
| Dec 1996 | $13.90M | - |
| Mar 1996 | - | $3.20M |
FAQ
- What is Avadel Pharmaceuticals plc annual total expenses?
- What is the all time high annual total expenses for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual total expenses year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly total expenses?
- What is the all time high quarterly total expenses for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly total expenses year-on-year change?
What is Avadel Pharmaceuticals plc annual total expenses?
The current annual total expenses of AVDL is $211.52M
What is the all time high annual total expenses for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual total expenses is $211.52M
What is Avadel Pharmaceuticals plc annual total expenses year-on-year change?
Over the past year, AVDL annual total expenses has changed by +$45.70M (+27.56%)
What is Avadel Pharmaceuticals plc quarterly total expenses?
The current quarterly total expenses of AVDL is $58.46M
What is the all time high quarterly total expenses for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly total expenses is $84.78M
What is Avadel Pharmaceuticals plc quarterly total expenses year-on-year change?
Over the past year, AVDL quarterly total expenses has changed by +$3.14M (+5.67%)